A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus
Clinical trial NCT01106651 · COMPLETED
Trial details
- NCT number
- NCT01106651
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-11-01
- Enrollment
- 716
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.